Synergistic Anti-Cancer Effects of Grape Seed Extract and Conventional Cytotoxic Agent Doxorubicin Against Human Breast Carcinoma Cells Girish SharmaAnil K. TyagiRajesh Agarwal OriginalPaper Pages: 1 - 12
Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer G.G. Van den EyndenI. Van der AuweraP.B. Vermeulen OriginalPaper Pages: 13 - 22
A Comparison of the Biological and Clinical Features of Invasive Lobular and Ductal Carcinomas of the Breast T. KorhonenH. HuhtalaK. Holli OriginalPaper Pages: 23 - 29
Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure Baoqing GuoDavid J. VilleneuveAmadeo M. Parissenti OriginalPaper Pages: 31 - 51
Sequential Versus Combined Treatment of Human Breast Cancer Cells with Antiestrogens and the Vitamin D Analogue EB1089 and Evaluation of Predictive Markers for Vitamin D Treatment G.L. ChristensenJ.S. JepsenA.E. Lykkesfeldt OriginalPaper Pages: 53 - 63
Selective Cytotoxicity of a Red Grape Wine Flavonoid Fraction Against MCF-7 Cells Fatima HakimuddinGopinadhan PaliyathKelly Meckling OriginalPaper Pages: 65 - 79
Are Medullary Breast Cancers an Indication for BRCA1 Mutation Screening? A Mutation Analysis of 42 Cases of Medullary Breast Cancer P.T.C. IauM. MarafieR.W. Blamey OriginalPaper Pages: 81 - 88
Association of Tamoxifen (TAM) and TAM Metabolite Concentrations with Self-Reported Side Effects of TAM in Women with Breast Cancer Lisa GallicchioGwyn LordJodi A. Flaws OriginalPaper Pages: 89 - 97